Feb 2013 - Global Lifesciences Business in India- News & Updates

Top Highlights for February 2013:  (Please click on news title to view details)

  1. India's Strides Arcolab inks pact to sell Agila Specialties to Mylan for $1.6 bilion (9,950 cr)
  2. India On Top For New York-based OrbiMed Advisors for its $500 million pan-Asia healthcare fund. (Asia Fund II)
  3. Venus Remedies,India grants exclusive marketing rights to S.Africa's Adcock for selling its novel antibiotic products
  4. India's Biocon inks pact with Mylan to make 3 insulin products
  5. Japanese pharma companies keen to collaborate with Indian companies
  6. Scotland eyes Indian Life science industry to boost bilateral trade owing to its huge potential market
  7. India is emerging as a hub for global pharma industry in Asia
  8. Indian pharmaceutical companies projected to grow 20% in 2013 

 

Aagami - Company Updates: